Leptin in relation to prostate cancer and benign prostatic hyperplasia

International Journal of Cancer

Volumn 76, Issue 1, 1998, Pages 25-28

  Lagiou, Pagona ^a,b   Signorello, Lisa B ^a   Trichopoulos, Dimitrios ^a,e   Tzonou, Anastasia ^c   Trichopoulou, Antonia ^b   Mantzoros, Christos S ^a,d  

^a University School of Public Health   (United States)

^b NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; LEPTIN; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C;

AGED; ARTICLE; BODY MASS; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ESTRADIOL BLOOD LEVEL; GONADOTROPIN RELEASE; HORMONAL REGULATION; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MARKER GENE; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; TESTOSTERONE BLOOD LEVEL;

EID: 0031979069     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19980330)76:1<25::aid-ijc5>3.0.co;2-%23     Document Type: Article

References (31)

1. AHIMA, R., PRABAKARAN, D., MANTZOROS, C., QU, D., LOWELL, B., MARATOS-FLIER, E. and FLIER, J.S., Role of leptin in the neuroendocrine response to fasting. Nature (Lond.), 382, 250-252 (1996).
2. AHIMA, R.S., DUSHAY, J., FLIER, S.N., PRABAKARAN, D. and FLIER, J.S., Leptin accelerates the timing of puberty in normal female mice. J. clin. Invest., 91, 391-395 (1997).
3. BARASH, I.A., CHEUNG, C.C., WEIGLE, D.S., REN, H., KABIGTING, E.B., KUIJPER, J.L., CLIFTON, D.K. and STEINER, R.A., Leptin is a metabolic signal to the reproductive system. Endocrinology, 137, 3144-3147 (1996).
4. BRESLOW, N.E. and DAY, N.E., Statistical methods in cancer research. Vol. I. The analysis of case-control studies. IARC Scientific Publication No. 32. International Agency for Research on Cancer, Lyon (1980).
5. BROCHU, M. and BELANGER, A., Comparative study of plasma steroid and steroid glucuronide levels in normal men and in men with benign prostatic hyperplasia. Prostate, 11, 33-40 (1987).
6. BRZECHFFA, P.R., JAKIMIUK, A.J., AGARWAL, S.K., WEITSMAN, S.R., BUYALOS, R.P. and MAGOFFIN, D.A., Serum immunoreactive leptin concentrations in women with polycystic ovarian disease. J. clin. Endocrinol. Metab., 81, 4166-4169 (1996).
7. CAMPFIELD, L.A., SMITH, F.J., CUISEZ, Y., DEVOS, R. and BURN, P., Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science, 269, 546-548 (1995).
8. CARO, J.F., SINHA, M.K., KOLACZYNSKI, J.W., ZHARY, P.L. and CONSIDINE, R.V., Leptin: the tale of an obesity gene. Diabetes, 45, 1455-1462 (1996).
9. CHEHAB, F., LIM, M. and LU, R., Correction of the sterility defect in homozygous obese female mice by treatment with human recombinant leptin. Nature (Genet.), 12, 318-320 (1996).
10. CHEBAB, F., MOUNZIH, K., LU, R. and LIM, M.E., Early onset of reproductive function in normal female mice treated with leptin. Science, 275, 88-90 (1997).
11. CONSIDINE, R.V., SINHA, M., HEIMAN, M., KRIAUCIUNAS, A., STEPHENS, T.W., NYCE, M.R., OHANNESIAN, J.P. MARCO, C.C., MCKEE, L.J., BAUER, T.L. and CARO, J.F., Serum immunoreactive leptin concentrations in normal weight and obese humans. N. Engl. J. Med., 334, 292-295 (1996).
12. FREDERICK, R.C., HAMANN, A., ANDERSON, S., LOLLMAN, B., LOWELL, B.B. and FLIER, J.S., Leptin reflects body lipid content in mice: evidence for diet-induced leptin resistance. Nature Med., 1, 1311-1314 (1995a).
13. FREDERICH, R.C., LOLLMANN, B., HAMANN, A., NAPOLITANO-ROSEN, A., KAHN, B.B., LOWELL, B.B. and FLIER, J.S., Expression of the ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J. clin. Invest., 96, 1658-1663 (1995b).
14. GANN, P.H., HENNEKENS, C.H., MA, J., LONGCOPE, C. and STAMPFER, M.J., Prospective study of sex hormone levels and risk of prostate cancer. J. nat. Cancer. Inst. 88, 1118-1126 (1996).
15. HALAAS, J.L., GAJIWALA, K.S., MAFFEI, M., COHEN, S.L., CHAIT, B.T., RABINOWITZ, D., LALLONE, R.L., BURLEY, S.K. and FRIEDMAN, J.M., Weight-reducing effects of plasma protein encoded by the obese gene. Science. 269, 543-546 (1995).
16. HOUSEKNECHT, K.L., MANTZOROS, C.S., KULIAWAT, R., HADRO, E., FLIER, J.S. and KHAN, B.B., Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes, 45, 1638-1643 (1996).
17. HSING, A.W. and COMSTOCK, G.W., Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer. Cancer Epidemiol. Biomarkers Prev., 2, 27-32 (1993).
18. LAGIOU, P., MANTZOROS, C.S., TZONOU, A., SIGNORELLO, L.B., LIPWORTH, L. and TRICHOPOULOS, D., Serum steroids in relation to benign prostatic hyperplasia. Oncology, 54, 407-501 (1997).
19. MAFFEI, M., HALAAS, J., RAVUSSIN, E., PRATLEY, R.E., LEE, G.H., ZHANG, Y., FBI, H., KIM, S., LALLONE, R., RANGANATHAN, S., KERN, P.A. and FRIEDMAN, J.M., Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med., 1, 1155-1161 (1995).
20. MANTZOROS, C.S., FLIER, J.S. and ROGOL, A.D., A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty. J. clin. Endocrinol. Metabol., 82, 1066-1070 (1997a).
21. MANTZOROS, C.S., TZONOU, A., SIGNORELLO, L.B., STAMPFER, M., TRICHOPOULOUS, D. and ADAMI, H.O., Insulin like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Brit. J. Cancer 76, 1115-1118 (1997b)
22. PELLEYMOUNTER, M.A., CULLEN, M.J., BAKER, M.B., HECHT, R., WINTERS, D., BOONE, T. and COLLINS, F., Effects of the obese gene product on body weight regulation in ob/ob mice. Science, 269, 540-543 (1995).
23. RINK, T.J., In search of a satiety factor. Nature (Lond.), 372, 406-407 (1995).
24. ROHNER-JEANRENAUD, F. and JEANRENAUD, B., Obesity, leptin and the brain. N. Engl. J. Med., 334, 324-325 (1996).
25. SIGNORELLO, L.B., TZONOU, A., MANTZOROS, C.S., LIPWORTH, L., LAGIOU, P., HSIEH, C-C., STAMPFER, M. and TRICHOPOULOS, D., Serum steroids in relation to prostate cancer risk in a case-control study (Greece). Cancer Causes Control, 8, 632-636 (1997).
26. SPIEGELMAN, B.M. and FLIER, J.S., Adipogenesis and obesity: rounding out the big picture. Cell 87, 377-389 (1996).
27. STATA CORPORATION, STATA, Release 5.0, Stata Corporation, Stata Statistical Software, College Station, TX (1997).
28. STEGE, R. and CARLSTROM, K., Testicular and adrenocortical function in healthy men and in men with benign prostatic hyperplasia. J. Steroid Biochem. Mol. Biol., 42, 357-362 (1992).
29. WEIGLE, D.S., BUKOWSKI, T.R., FOSTER, D.C., HOLDERMAN, S., KRAMER, J.M., LASSER, G., LOFTON-DAY, C.E., PRUNKARD, D.E., RAYMOND, C. and KUIJPER, J.L., Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J. clin. Invest., 96, 2065-2070 (1995).
30. YU, W.H., KIMURA, M. WALCREWSKA, A., KARANTH, F. and MCCANN, S.M., Role of leptin in hypothalamic pituitary function. Proc. nat. Acad. Sci. (Wash.), 94, 1023-1028 (1997).
31. ZHANG, Y., PROENCA, R., MAFFEI, M., BARONE, M., LEOPOLD, L. and FRIEDMAN, J.M., Positional cloning of the mouse ob gene and its human homologue. Nature (Lond.), 372, 435-432 (1994).